Covetrus, Inc. is an American company providing animal health products and related services.^[6] Until 2019, it was the animal health business of VetsFirstChoice, and Henry Schein, before being divested.^[7][6] In 2021, the company ranked 593 on the Fortune 1000 list of the largest United States corporations by total revenue.^[1]

Quick Facts Company type, Traded as ...

Covetrus, Inc.

Company type	Private
Traded as	Nasdaq: CVET
Industry	Animal health
Headquarters	Portland, Maine, US
Key people	Benjamin C. Wolin (president & CEO) Philip A. Laskawy (chairman)
Revenue	US$4,339 million (2021)[1]
Operating income	US$ −69 million (2020)[2]
Net income	US$108 million (2020)[3]
Total assets	US$3,496 million (2020)[4]
Total equity	US$1,573 million (2020)[4]
Owner	Clayton, Dubilier & Rice
Number of employees	5,500[5][1]
Website	covetrus.com

Close

In 2006, Henry Schein acquired NLS Animal Health, a privately held veterinary distribution business.^[8]

In 2009, Henry Schein and Butler Animal Health Supply launched a joint venture Butler Schein Animal Health creating the largest veterinary sales and distribution company in the United States.^[9]

In 2012, Henry Schein acquired Netherlands-based AUV Veterinary Services for approximately $40 million.^[10][11]

In 2013, Butler Schein Animal Health was rebranded as Henry Schein Animal Health.^[12][13]

In 2015, Scil Animal Care merged with Henry Schein Animal Health.^[14][15]

In 2016, Henry Schein acquired RxWorks, a provider of veterinary practice management software.^[16][17]

In 2019, Henry Schein announced the spin-off of its animal health business. The spin-off was merged with Portland, Maine-based Vets First Choice and was called Covetrus.^[18] The company became listed on the Nasdaq with Henry Schein shareholders owning about 63% of the company, and Vet First Choice shareholders owning about 37% of it.^[18][19]

In 2021, online pet product retailer Chewy Inc. filed a lawsuit against Covetrus for allegedly illegally diverting potential purchases of pet medication and food away from Chewy and into sales for Covetrus.^[20]

On May 25, 2022, it was announced that Clayton, Dubilier & Rice and TPG Inc. would acquire the company for $4 billion.^[21][22] The acquisition was finalized in October, 2022.^[23]

Covetrus engages in the sale of animal health consumable goods to wholesale and retail customers.^[24] Its products include supply chain services, software, and prescription management.^[25] The company's software services business develops and provides veterinary practices with veterinary software systems including practice management software, data-driven applicants, and client communications tools.^[25] The company operates primarily in North America, Europe, and Asia-Pacific.^[24] 100,000 veterinary practices are served by Covetrus globally.^[20]